Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 11, 2017
Multiplexed Reduced Representation Bisulfite Sequencing with Magnetic Bead Fragment Size SelectionWilliam P Accomando, Karin B Michels
Genome Biology|March 7, 2014
Quantitative reconstruction of leukocyte subsets using DNA methylationWilliam P Accomando, John K Wiencke, E Andres Houseman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2012
Decreased NK cells in patients with head and neck cancer determined in archival DNAWilliam P Accomando, John K Wiencke, E Andres Houseman, et al.
BMC Bioinformatics|May 10, 2012
DNA methylation arrays as surrogate measures of cell mixture distributionEugene Andres Houseman, William P Accomando, Devin C Koestler, et al.
Epigenetics|March 28, 2014
Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patientsScott M Langevin, E Andres Houseman, William P Accomando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with GliomaWilliam P Accomando, Aliz R Rao, Daniel J Hogan, et al.
NPJ Genomic Medicine|December 22, 2017
Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humansJuan J Carmona, William P Accomando, Alexandra M Binder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effectsJaime R Merchan, Jordi Rodon, Shree Venkat, et al.
Epigenetics|October 31, 2012
Epigenetic biomarkers of T-cells in human gliomaJohn K Wiencke, William P Accomando, Shichun Zheng, et al.
Oncotarget|May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor modelsLeah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.
Pageof 1